, Tracking Stock Market Picks
Enter Symbol:
Amgen Inc. (AMGN) [hlAlert]

up 47.61 %

Amgen Inc. (AMGN) rated Buy with price target $192 by Deutsche Bank

Posted on: Thursday,  May 28, 2015  12:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Amgen Inc. (NASDAQ: AMGN) on 05/28/2015. Previously Deutsche Bank rated Buy Amgen Inc. (NASDAQ: AMGN) on 04/24/2013.,
when the stock price was $105.49. Since then, Amgen Inc. has gained 47.62% as of 08/27/2015's recent price of $155.72.
If you would have followed the previous Deutsche Bank's recommendation on AMGN, you would have gained 47.61% of your investment in 855 days.

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/28/2015 12:25 PM Buy
157.91 192.00
as of 8/27/2015
1 Week down  -9.62 %
1 Month down  -3.69 %
3 Months down  -3.86 %
1 YTD up  36.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2013 1:25 PM Buy
116.11 142.00
4/24/2013 4:25 PM Buy
105.49 115.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy